Biome Sciences

Biome Sciences is a pre-clinical stage biotechnology company developing a novel therapeutic delivery platform based on the skin microbiome. The company's proprietary S-GARD (Skin-Grown Antigen-Response Delivery) technology engineers commensal skin bacteria to produce and deliver therapeutic proteins directly to the host. This approach is designed to provide continuous, needle-free delivery of vaccines and treatments for inflammatory skin diseases like atopic dermatitis. By leveraging the natural persistence of skin microbes, Biome Sciences aims to eliminate the need for cold-chain logistics and frequent dosing. The company is currently focused on advancing its lead programs in infectious disease prevention and dermatological health.